EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins



Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins



Journal of Clinical Investigation 76(2): 575-585



To quantify more precisely the metabolism of apolipoprotein B (apo B) in human beings, an integrated model was developed for the analysis of the isotope kinetics of apo B in very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), and low density lipoproteins (LDL). The experimental basis for model development was a series of 30 triple-isotope studies in which patients received autologous 131I-VLDL, 125I-IDL, and [3H]glycerol as a precursor of VLDL triglycerides. The currently proposed model contains the following components: (a) a VLDL delipidation cascade that has a variable number of subcompartments, (b) a slowly catabolized pool of VLDL, (c) an IDL compartment consisting of two closely connected subcompartments, one of which is outside the immediate circulation, and (d) a two-compartment subsystem for LDL. Because mass data indicate that not all VLDL were converted to LDL, the model allows for irreversible removal of apo B from VLDL (or IDL) subsystems. It accounts for apparent "direct" input of LDL by postulating an early, rapidly metabolized compartment of VLDL that is converted directly to IDL. The model appears to be consistent with specific activity curves from the current triple-isotope studies and with present concepts of lipoprotein physiology; it also can be used to quantify pathways of lipoprotein apo B transport in normal and abnormal states.

(PDF same-day service: $19.90)

Accession: 005132483

Download citation: RISBibTeXText

PMID: 4031063

DOI: 10.1172/JCI112009



Related references

Lipolysis products promote the formation of complexes of very low density lipoproteins and low density lipoproteins and the association of apolipoprotein a i with very low density lipoproteins and low density lipoproteins. Clinical Research 34(2): 550A, 1986

Electrophoretic mobility of apolipoprotein b in very low density lipoproteins intermediate density lipoproteins and low density lipoproteins of normal subjects. Bulletin Of Molecular Biology & Medicine: 175-182, 1984

The transformation of nascent disc shaped high density lipoproteins into mature spherical high density lipoproteins: conformational analysis of apolipoprotein A-I in model intermediate particles. Journal of Theoretical Biology 169(2): 143-152, 1994

Gradient acrylamide/agarose gels for electrophoretic separation of intact human very low density lipoproteins, intermediate density lipoproteins, lipoprotein a, and low density lipoproteins. Analytical Biochemistry 162(2): 420-426, 1987

Plasma distribution of cyclosporine within lipoproteins and "in vitro" transfer between very-low-density lipoproteins, low-density lipoproteins, and high-density lipoproteins. Therapeutic Drug Monitoring 13(4): 289-295, 1991

Characterization of very low density lipoproteins and intermediate density lipoproteins of normo lipidemic and hyperlipidemic apolipoprotein e 2 homozygotes. Journal of Lipid Research 26(3): 316-326, 1985

Lipoproteins in human atherosclerotic vessels. I. Biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins. Experimental and Molecular Pathology 30(2): 144-171, 1979

Gradient acrylamide agarose gels for electrophoretic separation of intact human very low density lipoproteins intermediate lipoproteins lipoprotein a and low density lipoproteins. Analytical Biochemistry 162(2): 420-426, 1987

Characterization of very low density lipoproteins and intermediate density lipoproteins of normo- and hyperlipidemic apolipoprotein E-2 homozygotes. Journal of Lipid Research 26(3): 316-326, 1985

Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. Journal of Clinical Investigation 101(10): 2151-2164, 1998

Structural organization of apolipoprotein B-100 of human plasma low density lipoproteins. Comparison to B-48 of chylomicrons and very low density lipoproteins. Journal of Biological Chemistry 261(35): 16744-8, 1986

Sequence of alcohol induced initial changes in plasma lipoproteins very low density lipoproteins and high density lipoproteins and lipolytic enzymes in humans. Metabolism Clinical & Experimental 34(2): 112-119, 1985

Transgenic rabbits that overexpress hepatic lipase have a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Woodford, F P, Davignon, J, Sniderman, A International Congress Series; Atherosclerosis X 666-669, 1995

Overproduction of small very low density lipoproteins (Sf 20-60) in moderate hypercholesterolemia: relationships between apolipoprotein B kinetics and plasma lipoproteins. Journal of Lipid Research 36(1): 158-171, 1995

Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proceedings of the National Academy of Sciences of the United States of America 91(18): 8724-8728, 1994